Skip to main content

Table 3 Demographics of individuals with chronic HBV and acute HIV-1 co-infection

From: Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1)

    v1    v2    v3  
Patient HBeAg HBV DNAa HIV RNAa CD4 count HBV DNAa HIV RNAa CD4 count HBV DNAa HIV RNAa CD4 count
AHI01 pos 8.45 5.66 376 7.38 5.66 212 3.52b <ldlb 376
AHI02 pos 6.54 4.55 533 7.43 4 298 7.76 ND 405
AHI03 neg <ldl 3.89 213 <ldl ND 192 <ldl ND 189
AHI04 pos 7.71 3.75 345 8.2 4.47 275 8.4 ND 342
AHI05 pos 9.04 5.72 363 8.32 ND 292 7.14 ND 363
AHI06 neg <ldl 2.23 361 <ldl ND 345 <ldl ND 221
AHI07 pos 8.14 6.1 412 8.45 ND 329 7.54 ND 293
AHI08 neg <ldl 4.92 308 <ldl 4.67 365 <ldl ND 395
AHI09 neg <ldl 3.39 922 <ldl 3.3 862 <ldl ND 692
AHI10 neg <ldl 6.31 380 <ldl ND 464 <ldl ND 243
AHI11 neg <ldl 5.62 221 <ldl ND 445 <ldl ND 445
  1. pos HBeAg positive, neg HBeAg negative; v1, 2, 3: followed up on 3rd, 12th, 24th month post acute HIV-1 infection; alog10; bHAART with AZT/3TC/LPVr; ldl lower limit of detection, ND not done.